In accordance with the cancer stem cell models that posit only a rare subset of cells are tumor-initiating cells, several markers for prostate cancer stem cells have been reported including the cell surface markers CD44 and CD133 [14,15]. This evidence concerns the gene PROM1 and neoplasm.